Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis.

@article{Zhu2013StatinTI,
  title={Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis.},
  author={Qianqian Zhu and Na Li and Qunying Han and Pingping Zhang and Cuiling Yang and Xiaoyan Zeng and Yanping Chen and Yi Lv and Xi Liu and Zhengwen Liu},
  journal={Antiviral research},
  year={2013},
  volume={98 3},
  pages={373-9}
}
The treatment of interferon alfa (IFN-α) and ribavirin for chronic hepatitis C virus (HCV) infection achieves limited sustained virological response (SVR). We conducted a systematic review and meta-analysis to explore the efficacy of adding statins to IFN-α and ribavirin therapy for chronic hepatitis C. Studies with data pertinent to the effect of statins on chronic hepatitis C were reviewed, and randomized controlled trials (RCTs) evaluating the efficacy of the addition of statins to IFN-α and… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 70 references

Potential enhancement of both early (EVR) and sustained(SVR) virological response by fluvasatin in chronic hepatitis C treated standard PegIFN-ribavirin therapy

  • E. F. Georgescu, L. Streba, R. Teodorescu, G. Mateescu, M. Tataru Abagiu
  • A pilot study. J. Hepatol
  • 2011
Highly Influential
8 Excerpts

A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naive genotype one hepatitis C patients

  • T. Bader, L. D. Hughes, +4 authors M. F. Madhoun
  • Gastroenterology 142,
  • 2012
Highly Influential
7 Excerpts

Similar Papers

Loading similar papers…